Population pharmacokinetic model of cefepime for critically ill adults: a comparative assessment of eGFR equations
Antimicrobial Agents and Chemotherapy · 15.11.2023 · 67 (11)
DOI: 10.1128/aac.00810-23 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, erschienen am 15.11.2023. Verfasst von Erin F Barreto und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Mayo Clinic , Rochester, Minnesota, USA. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Cystatin C. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, HHS | NIH | National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
Cefepime exhibits highly variable pharmacokinetics in critically ill patients. The purpose of this study was to develop and qualify a population pharmacokinetic model for use in the critically ill and investigate the impact of various estimated glomerular filtration rate (eGFR) equations using creatinine, cystatin C, or both on model parameters. This was a prospective study of critically ill adults hospitalized at an academic medical center treated with intravenous cefepime. Individuals with acute kidney injury or on kidney replacement therapy or extracorporeal membrane oxygenation were excluded. A nonlinear mixed-effects population pharmacokinetic model was developed using data collected from 2018 to 2022. The 120 included individuals contributed 379 serum samples for analysis. A two-compartment pharmacokinetic model with first-order elimination best described the data. The population mean parameters (standard error) in the final model were 7.84 (0.24) L/h for CL1 and 15.6 (1.45) L for V1. Q was fixed at 7.09 L/h and V2 was fixed at 10.6 L, due to low observed interindividual variation in these parameters. The final model included weight as a covariate for volume of distribution and the eGFR cr-cysC (mL/min) as a predictor of drug clearance. In summary, a population pharmacokinetic model for cefepime was created for critically ill adults. The study demonstrated the importance of cystatin C to prediction of cefepime clearance. Cefepime dosing models which use an eGFR equation inclusive of cystatin C are likely to exhibit improved accuracy and precision compared to dosing models which incorporate an eGFR equation with only creatinine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Mayo Clinic , Rochester, Minnesota, USA.
- Department of Pharmacy Practice, Chicago College of Pharmacy, Pharmacometrics Center of Excellence, Midwestern University , Downers Grove, Illinois, USA.
- Department of Pharmacy, Northwestern Medicine , Chicago, Illinois, USA.
- Division of Nephrology and Hypertension, Mayo Clinic , Rochester, Minnesota, USA.
- Division of Epidemiology, Mayo Clinic , Rochester, Minnesota, USA.
- Division of Clinical Trials and Biostatistics, Mayo Clinic , Rochester, Minnesota, USA.
ORCID-Profile: Erin F Barreto, Marc H Scheetz
Förderung
- NIAID NIH HHS
- HHS | NIH | National Institute of Allergy and Infectious Diseases
Zitieren
APA
Barreto, E. F., Chang, J., Rule, A. D., Mara, K. C., Meade, L. A., Paul, J., Jannetto, P. J., Athreya, A. P., Scheetz, M. H., & BLOOM Study Group (2023). Population pharmacokinetic model of cefepime for critically ill adults: a comparative assessment of eGFR equations. Antimicrobial Agents and Chemotherapy, 67(11). https://doi.org/10.1128/aac.00810-23
Vancouver
Barreto EF, Chang J, Rule AD, Mara KC, Meade LA, Paul J, et al. Population pharmacokinetic model of cefepime for critically ill adults: a comparative assessment of eGFR equations. Antimicrobial Agents and Chemotherapy. 2023;67(11). doi:10.1128/aac.00810-23
BibTeX
@article{Barreto2023,
author = {Barreto, Erin F and Chang, Jack and Rule, Andrew D and Mara, Kristin C and Meade, Laurie A and Paul, Johar and Jannetto, Paul J and Athreya, Arjun P and Scheetz, Marc H and BLOOM Study Group, BLOOM Study Group},
title = {Population pharmacokinetic model of cefepime for critically ill adults: a comparative assessment of eGFR equations},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2023},
volume = {67},
number = {11},
doi = {10.1128/aac.00810-23}
}
EUVIMED